These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 13444134)

  • 1. [Hemolytic disease of newborn in sensitization of mothers by blood transfusions].
    POLIAKOVA GP
    Akush Ginekol (Mosk); 1957; 33(3):9-13. PubMed ID: 13444134
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of sensitization of the mother after blood transfusion on the severity of hemolytic disease of newborn].
    KOZLOWSKA J
    Pol Arch Med Wewn; 1956; 26(12):1847-50. PubMed ID: 13419757
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood transfusion incident and erythroblastosis due to anti-cE].
    HOPPE HH
    Klin Wochenschr; 1954 Oct; 32(39-40):975-7. PubMed ID: 13222781
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dangers of blood injections in women].
    MONGIN M
    Mars Med; 1951; 88(10):486-8. PubMed ID: 14918674
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hemolytic disease of the newborn in first-born children and importance of prior transfusions in the mothers. Study of 7 cases].
    SANSONE G; CERRUTI P
    Minerva Pediatr; 1960 Nov; 12():1523-6. PubMed ID: 13746296
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemolytic disease of the newborn infant caused by maternal sensitization to the blood factor hr, report of two cases with special reference to the etiologic significance of multiple blood transfusions in Rh positive women prior to gestation.
    GRUNDORFER J
    Blood; 1953 Jul; 8(7):609-19. PubMed ID: 13059046
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythroblastosis fetalis due to maternal sensitization to Hr factor by blood transfusion.
    GOODMAN HL
    J Med Soc N J; 1962 Aug; 59():468-70. PubMed ID: 13900306
    [No Abstract]   [Full Text] [Related]  

  • 8. A summary of atypical antibodies, rare genotypes, and ABO hemolytic disease encountered in a one year survey.
    BUSHNELL LN; LEVINE P; MCGEE R; ROBINSON E; STROUP M
    Blood; 1956 Dec; 11(12):1097-117. PubMed ID: 13373928
    [No Abstract]   [Full Text] [Related]  

  • 9. [A case of hemolytic disease of newborn probably due to antibodies of Lewis blood group system].
    SCHWENZER AW; SPIELMANN W
    Vox Sang; 1957 Dec; 2(6):428-33. PubMed ID: 13530913
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nil nocere: "Simultaneous immunization in the Rhesus and Kell systems by repeated blood transfusions"].
    JUNGWIRTH J; WELSCH H
    Munch Med Wochenschr; 1960 Jun; 102():1190-2. PubMed ID: 14408221
    [No Abstract]   [Full Text] [Related]  

  • 11. [THE TREATMENT OF HEMOLYTIC DISEASE OF THE NEWBORN BY EXCHANGE TRANSFUSION AND FRACTIONAL BLOOD TRANSFUSIONS].
    BURENKOVA LV
    Probl Gematol Pereliv Krovi; 1964 May; 9():24-7. PubMed ID: 14242573
    [No Abstract]   [Full Text] [Related]  

  • 12. Excess of group O mothers in A-B-O hemolytic disease, with special reference to the rĂ´le of blood factor C.
    WIENER AS; UNGER LJ
    Exp Med Surg; 1955; 13(3):204-24. PubMed ID: 13262059
    [No Abstract]   [Full Text] [Related]  

  • 13. [Blood groups and transfusions].
    BRAY G
    Rev Belge Stomatol; 1953 Jun; 50(2):199-223. PubMed ID: 13101076
    [No Abstract]   [Full Text] [Related]  

  • 14. [Severe erythroblastosis fetalis in a first born child due to prior sensitization of the mother by blood transfusion].
    HERZOG M
    Dtsch Med Wochenschr; 1950 Oct; 75(40):1341. PubMed ID: 14793120
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical, prophylactic and therapeutic survey of accidents due to Rh-factors].
    SCHULZE S
    Dtsch Gesundheitsw; 1952 Nov; 7(46):1442-9. PubMed ID: 13043272
    [No Abstract]   [Full Text] [Related]  

  • 16. [Twenty-one cases of hemolytic disease of the newborn treated by fractional exchange transfusions].
    MOULINIER J
    J Med Bord; 1951 Apr; 128(4):490-2. PubMed ID: 14832552
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of exchange transfusion for the treatment of severe erythroblastosis due to A-B sensitization, with observations on the pathogenesis of the disease.
    WIENER AS; WEXLER IB; HURST JG
    Blood; 1949 Sep; 4(9):1014-32. PubMed ID: 18134767
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical features, serology and pathogenesis of erythroblastosis in newborn of diabetic mother].
    FULLING G; LODENKAMPER H
    Z Kinderheilkd; 1953; 73(2):174-87. PubMed ID: 13103373
    [No Abstract]   [Full Text] [Related]  

  • 19. Practical application of the Rh factor in congenital hemolytic anemia of the newborn (erythroblastosis fetalis), habitual abortion, and blood transfusions.
    HAYMOND JL; GIORDANO AS
    J Indiana State Med Assoc; 1946 Sep; 39():429-35. PubMed ID: 20996186
    [No Abstract]   [Full Text] [Related]  

  • 20. [Blood transfusion and isoimmunization by Rh factor; hemolytic disease of the newborn].
    MATA DE LA CAMPA M
    Med Esp; 1961 Dec; 46():479-82. PubMed ID: 14471040
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.